AVALO THERAPEUTICS, INC. Other Nonoperating Income (Expense)
AVALO THERAPEUTICS, INC. (AVTX) reported Other Nonoperating Income (Expense) of -$3.00 thousand for the 3-month period ending 2025-09-30, per its 10-Q filed 2025-11-06.
Financial Statements › Income Statement › Other Income
us-gaap:OtherNonoperatingIncomeExpense · last filed 2025-11-06
- AVALO THERAPEUTICS, INC. other nonoperating income (expense) for the quarter ending 2025-09-30 was -$3.00K.
- AVALO THERAPEUTICS, INC. other nonoperating income (expense) for the quarter ending 2025-06-30 was -$5.00K.
- AVALO THERAPEUTICS, INC. other nonoperating income (expense) for the quarter ending 2024-12-31 was $0.00.
- AVALO THERAPEUTICS, INC. other nonoperating income (expense) for the quarter ending 2024-09-30 was -$5.00K.
- AVALO THERAPEUTICS, INC. other nonoperating income (expense) for fiscal 2024 was -$5.00K.
- AVALO THERAPEUTICS, INC. other nonoperating income (expense) for fiscal 2023 was -$42.00K.
- AVALO THERAPEUTICS, INC. other nonoperating income (expense) for fiscal 2022 was -$20.00K.
- AVALO THERAPEUTICS, INC. other nonoperating income (expense) for fiscal 2021 was -$20.00K, a 104.89% decline from fiscal 2020.
| Period end | Other Nonoperating Income (Expense) 3 month | Other Nonoperating Income (Expense) 6 month | Other Nonoperating Income (Expense) 9 month | Other Nonoperating Income (Expense) 12 month | Other Nonoperating Income (Expense) 12 month as first filed |
|---|---|---|---|---|---|
| 2025-09-30 | -$3.00K 10-Q · filed 2025-11-06 | -$8.00K derived: sum of 2 quarters · filed 2025-11-06 | -$8.00K 10-Q · filed 2025-11-06 | ||
| 2025-06-30 | -$5.00K 10-Q · filed 2025-08-07 | -$5.00K 10-Q · filed 2025-08-07 | |||
| 2024-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-20 | -$5.00K derived: sum of 2 quarters · filed 2025-11-06 | -$5.00K derived: sum of 3 quarters · filed 2025-11-06 | -$5.00K 10-K · filed 2025-03-20 | |
| 2024-09-30 | -$5.00K 10-Q · filed 2025-11-06 | -$5.00K derived: sum of 2 quarters · filed 2025-11-06 | -$5.00K 10-Q · filed 2025-11-06 | -$5.00K derived: sum of 4 quarters · filed 2025-11-06 | |
| 2024-06-30 | $0.00 10-Q · filed 2025-08-07 | $0.00 10-Q · filed 2025-08-07 | $0.00 derived: sum of 3 quarters · filed 2025-08-07 | -$17.00K derived: sum of 4 quarters · filed 2025-08-07 | |
| 2024-03-31 | $0.00 10-Q/A · filed 2024-07-11 | $0.00 derived: sum of 2 quarters · filed 2025-03-20 | -$17.00K derived: sum of 3 quarters · filed 2025-03-20 | -$17.00K derived: sum of 4 quarters · filed 2025-03-20 | |
| 2023-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-20 | -$17.00K derived: sum of 2 quarters · filed 2025-03-20 | -$17.00K derived: sum of 3 quarters · filed 2025-03-20 | -$42.00K 10-K · filed 2025-03-20 | |
| 2023-09-30 | -$17.00K 10-Q · filed 2024-11-07 | -$17.00K derived: sum of 2 quarters · filed 2024-11-07 | -$42.00K 10-Q · filed 2024-11-07 | -$43.00K derived: sum of 4 quarters · filed 2024-11-07 | |
| 2023-06-30 | $0.00 10-Q · filed 2024-08-12 | -$25.00K 10-Q · filed 2024-08-12 | -$26.00K derived: sum of 3 quarters · filed 2024-08-12 | -$26.00K derived: sum of 4 quarters · filed 2024-08-12 | |
| 2023-03-31 | -$26.00K 10-Q/A · filed 2024-07-11 | -$26.00K derived: sum of 2 quarters · filed 2024-07-11 | -$26.00K derived: sum of 3 quarters · filed 2024-07-11 | -$26.00K derived: sum of 4 quarters · filed 2024-07-11 | |
| 2022-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-29 | $0.00 derived: sum of 2 quarters · filed 2024-03-29 | $0.00 derived: sum of 3 quarters · filed 2024-03-29 | -$20.00K 10-K · filed 2024-03-29 | |
| 2022-09-30 | $0.00 10-Q · filed 2023-11-09 | $0.00 derived: sum of 2 quarters · filed 2023-11-09 | -$20.00K 10-Q · filed 2023-11-09 | -$20.00K derived: sum of 4 quarters · filed 2023-11-09 | |
| 2022-06-30 | $0.00 10-Q · filed 2023-08-03 | -$20.00K 10-Q · filed 2023-08-03 | -$20.00K derived: sum of 3 quarters · filed 2023-08-03 | -$35.00K derived: sum of 4 quarters · filed 2023-08-03 | |
| 2022-03-31 | -$20.00K 10-Q · filed 2023-05-04 | -$20.00K derived: sum of 2 quarters · filed 2023-05-04 | -$35.00K derived: sum of 3 quarters · filed 2023-05-04 | -$40.00K derived: sum of 4 quarters · filed 2023-05-04 | |
| 2021-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-29 | -$15.00K derived: sum of 2 quarters · filed 2023-03-29 | -$20.00K derived: sum of 3 quarters · filed 2023-03-29 | -$20.00K 10-K · filed 2023-03-29 | |
| 2021-09-30 | -$15.00K 10-Q · filed 2022-11-07 | -$20.00K derived: sum of 2 quarters · filed 2022-11-07 | -$20.00K 10-Q · filed 2022-11-07 | -$58.00K derived: sum of 4 quarters · filed 2022-11-07 | |
| 2021-06-30 | -$5.00K 10-Q · filed 2022-08-04 | -$5.00K 10-Q · filed 2022-08-04 | -$43.00K derived: sum of 3 quarters · filed 2022-08-04 | -$24.00K derived: sum of 4 quarters · filed 2022-08-04 | |
| 2021-03-31 | $0.00 10-Q · filed 2022-05-05 | -$38.00K derived: sum of 2 quarters · filed 2022-05-05 | -$19.00K derived: sum of 3 quarters · filed 2022-05-05 | $379.00K derived: sum of 4 quarters · filed 2022-05-05 | |
| 2020-12-31 | -$38.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-02 | -$19.00K derived: sum of 2 quarters · filed 2022-03-02 | $379.00K derived: sum of 3 quarters · filed 2022-03-02 | $409.00K 10-K · filed 2022-03-02 | $409.85K 10-K · filed 2021-03-08 |
| 2020-09-30 | $19.00K 10-Q · filed 2021-11-09 | $417.00K derived: sum of 2 quarters · filed 2021-11-09 | $447.00K 10-Q · filed 2021-11-09 | ||
| 2020-06-30 | $398.00K 10-Q · filed 2021-08-02 | $410.00K 10-Q · filed 2021-08-02 | |||
| 2020-03-31 | $11.00K 10-Q · filed 2021-05-13 | ||||
| 2019-12-31 | -$28.29K 10-K · filed 2021-03-08 | -$24.40K 10-K · filed 2020-03-11 | |||
| 2018-12-31 | $13.66K 10-K · filed 2020-03-11 | ||||
| 2017-12-31 | $0.00 10-K · filed 2019-03-18 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Immix Biopharma, Inc. (IMMX) | United States | $0.837B | -18.44 |
| Obsidian Therapeutics, Inc. (OBX) | United States | $0.829B | |
| ARDELYX, INC. (ARDX) | United States | $0.857B | -22.86 |
| LEXICON PHARMACEUTICALS, INC. (LXRX) | United States | $0.823B | -17.48 |
| GYRE THERAPEUTICS, INC. (GYRE) | United States | $0.818B | -24.71 |
| GERON CORP (GERN) | United States | $0.803B | -12.14 |
| Cryoport, Inc. (CYRX) | United States | $0.881B | -21.29 |
| Theravance Biopharma, Inc. (TBPH) | $0.885B | 16.40 | |
| Aclaris Therapeutics, Inc. (ACRS) | United States | $0.792B | -9.78 |
| RIGEL PHARMACEUTICALS INC (RIGL) | United States | $0.893B | 2.25 |